STONERIDGE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that STONERIDGE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $824.44M | Mar 7, 2018 |
| FY2017 | Dec 31, 2016 | $695.98M | Mar 7, 2018 |
| FY2017 | Dec 31, 2015 | $644.81M | Mar 7, 2018 |
| FY2016 | Dec 31, 2014 | $660.58M | Mar 2, 2017 |
| FY2015 | Dec 31, 2013 | $659.49M | Mar 14, 2016 |
| FY2014 | Dec 31, 2012 | $612.47M | Mar 13, 2015 |
| FY2013 | Dec 31, 2011 | $765.37M | Mar 7, 2014 |
| FY2012 | Dec 31, 2010 | $635.23M | Mar 8, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $861.26M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $908.30M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $975.82M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $899.92M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $770.46M | Mar 1, 2024 |
| FY2020 | Dec 31, 2020 | $189.73M | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | $175.76M | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | $99.55M | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | $182.97M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $190.37M | Feb 24, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $207.44M | Mar 7, 2018 |
| FY2017 | Sep 30, 2017 | $203.58M | Mar 7, 2018 |
| FY2017 | Jun 30, 2017 | $209.11M | Mar 7, 2018 |
| FY2017 | Mar 31, 2017 | $204.31M | Mar 7, 2018 |
| FY2017 | Dec 31, 2016 | $172.61M | Mar 7, 2018 |
| FY2017 | Sep 30, 2016 | $173.85M | Mar 7, 2018 |
| FY2017 | Jun 30, 2016 | $186.90M | Mar 7, 2018 |
| FY2017 | Mar 31, 2016 | $162.62M | Mar 7, 2018 |
| FY2016 | Dec 31, 2015 | $154.64M | Mar 2, 2017 |
| FY2016 | Sep 30, 2015 | $162.06M | Mar 2, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $49.55M | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | $46.00M | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | $13.25M | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | $45.40M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $44.20M | Feb 24, 2021 |
| FY2020 | Sep 30, 2019 | $51.86M | Feb 24, 2021 |
| FY2020 | Jun 30, 2019 | $56.83M | Feb 24, 2021 |
| FY2020 | Mar 31, 2019 | $60.85M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $57.96M | Feb 27, 2020 |
| FY2019 | Sep 30, 2018 | $63.29M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($102.84M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($16.52M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | ($5.18M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | ($14.06M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $3.41M | Mar 1, 2024 |
| FY2019 | Dec 31, 2019 | $60.29M | Feb 27, 2020 |
| FY2019 | Dec 31, 2018 | $53.85M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $18.91M | Feb 28, 2019 |
| FY2018 | Sep 30, 2017 | $8.05M | Feb 28, 2019 |
| FY2018 | Jun 30, 2017 | $9.02M | Feb 28, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($38.61M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($381.0K) | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $12.84M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $2.94M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $15.41M | Mar 1, 2024 |
| FY2020 | Dec 31, 2020 | $5.67M | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | $9.83M | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | ($26.82M) | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | $3.66M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $1.07M | Feb 24, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.53M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $72.17M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $71.08M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $65.30M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $66.17M | Mar 1, 2024 |
| FY2022 | Dec 31, 2020 | $49.39M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $52.20M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $51.07M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $48.88M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $40.21M | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $125.61M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $117.46M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $117.40M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $106.70M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $116.00M | Mar 1, 2024 |
| FY2022 | Dec 31, 2020 | $112.47M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $123.85M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $138.55M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $141.89M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $111.15M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.02M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $47.75M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $4.95M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $6.81M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($36.25M) | Mar 1, 2024 |
| FY2022 | Dec 31, 2020 | $28.64M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $24.51M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $80.77M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $78.91M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $65.28M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $27.23M | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | $22.95M | Mar 2, 2023 |
| FY2022 | Dec 31, 2020 | $27.66M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $35.82M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $29.03M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $32.17M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $24.48M | Feb 28, 2019 |
| FY2017 | Dec 31, 2015 | $28.74M | Mar 7, 2018 |
| FY2016 | Dec 31, 2014 | $24.75M | Mar 2, 2017 |
| FY2015 | Dec 31, 2013 | $25.34M | Mar 14, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $551.19M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $621.56M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $679.90M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $652.11M | Mar 1, 2024 |
| FY2022 | Dec 31, 2021 | $665.40M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $621.41M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $602.21M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $559.52M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $559.04M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $394.53M | Mar 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $179.78M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $245.26M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $287.72M | Mar 16, 2026 |
| FY2025 | Dec 31, 2022 | $280.94M | Mar 16, 2026 |
| FY2024 | Dec 31, 2021 | $295.95M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $296.63M | Mar 1, 2024 |
| FY2022 | Dec 31, 2019 | $289.90M | Mar 2, 2023 |
| FY2017 | Dec 31, 2017 | $244.07M | Mar 7, 2018 |
| FY2017 | Dec 31, 2016 | $178.32M | Mar 7, 2018 |
| FY2016 | Dec 31, 2015 | $93.12M | Mar 2, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.59M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $33.09M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $35.30M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $34.23M | Mar 1, 2024 |
| FY2022 | Dec 31, 2021 | $36.39M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $39.10M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $35.87M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $36.72M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $38.42M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $931.0K | Mar 7, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.15M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $179.99M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $196.51M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $201.69M | Mar 1, 2024 |
| FY2022 | Dec 31, 2021 | $215.75M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $212.34M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $206.54M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $146.25M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $92.26M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $45.36M | Mar 7, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.25M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $71.83M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $40.84M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $54.80M | Mar 1, 2024 |
| FY2022 | Dec 31, 2021 | $85.55M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $73.92M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $69.40M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $81.09M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $66.00M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $50.39M | Feb 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $180.94M | Mar 16, 2026 |
| FY2024 | Dec 31, 2024 | $201.58M | Mar 3, 2025 |
| FY2023 | Dec 31, 2023 | $191.46M | Mar 1, 2024 |
| FY2022 | Dec 31, 2022 | $169.25M | Mar 2, 2023 |
| FY2021 | Dec 31, 2021 | $169.21M | Feb 28, 2022 |
| FY2020 | Dec 31, 2020 | $143.67M | Feb 24, 2021 |
| FY2019 | Dec 31, 2019 | $129.13M | Feb 27, 2020 |
| FY2018 | Dec 31, 2018 | $98.52M | Feb 28, 2019 |
| FY2017 | Dec 31, 2017 | $129.04M | Mar 7, 2018 |
| FY2016 | Dec 31, 2016 | $83.69M | Mar 2, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 1, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 1, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.02M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 27.70M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | 27.55M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 27.34M | Mar 1, 2024 |
| FY2022 | Dec 31, 2021 | 27.19M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | 27.01M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 27.41M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 28.49M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 28.18M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 27.85M | Mar 7, 2018 |